Paxlovid Is a Fraud, When Will It Be Taken Off the Market?

Fight Censorship, Share This Post!

Video Link

Pfizer’s revenue is expected to reach $101.3 billion in 2022,40 thanks to the COVID jab and Paxlovid ($10 billion from Paxlovid alone) — both of which are frauds. Neither of them actually work as advertised, and both can make matters worse. In the case of Pfizer’s COVID-19 shot, you can still get the disease once you’ve been injected and boosted, and may still transmit the disease to others as well.

Then, when the shots don’t work to prevent infection — and we’ve now seen even five doses won’t prevent infection — Pfizer makes even more money by selling Paxlovid, which in many cases causes rebound! There can be only one reason for why the FDA has not withdrawn both of these drugs, and that is because they’re actually working for Pfizer.

Pfizer itself doesn’t view COVID rebound after Paxlovid treatment as a failure; they see it as a successful venture because the more courses needed, the more money they make. As reported by the Kaiser Family Foundation (KFF) in early July 2022:41

“During a recent investor call, a Pfizer official could spin the recent reports that the virus can hide from Paxlovid into good news, predicting that, as with the vaccine, patients may need multiple courses.

Immunocompromised patients ‘may carry this virus for a very, very long time,’ Dr. Mikael Dolsten [chief scientist and President of Worldwide Research and Development at Pfizer42] said in the investor call. ‘And we see that area as a real new opportunity growth area for Paxlovid to do very well, where you may need to take multiple courses.’”

FDA and CDC Are Extensions of the Drug Industry

Pushing a drug that causes COVID rebound does not appear to be in the best interest of public health. Paxlovid is a fraud and should be taken off the market. The fact that the FDA and CDC have focused on Paxlovid, remdesivir and molnupiravir to the exclusion of all others, including older drugs with high rates of effectiveness and superior safety profiles, sends a very disturbing message.

They’ve basically become extensions of the drug industry and have abandoned their original purpose, which is to protect public health — by ensuring the safety and efficacy of drugs, in the case of the FDA,43 and by conducting critical science and data analysis in the case of the CDC.44

Instead, they seem to be doing everything they can to protect Big Pharma profits, even if it costs you your life. Remdesivir, for example, costs between $2,340 and $3,120 depending on your insurance.45 Ivermectin, meanwhile — which has been very effective against COVID and shown to outperform at least 10 other drugs, including Paxlovid46 — costs between $4847 and $9448 for 20 pills depending on your location. The average cost is said to be about $58 per treatment.49

Paxlovid costs $529 per five-day course of treatment,50 and molnupiravir is around $700.51 While not quite as expensive as remdesivir, both are still nearly 10 times costlier than ivermectin, which is more effective. Imagine the billions of dollars we could have saved were it not for our health agencies being so compromised by industry.

Since the FDA and CDC cannot be trusted, it’s imperative to take responsibility for your own health. Do your own research and follow your own conscience and conviction. Remember, when it comes to COVID-19, early treatment is crucial, and effective protocols are readily available — just not from the FDA, CDC or even most hospitals.

For a refresher, check out Dr. Pierre Kory’s interview with Chris Martenson. You can also find many other articles describing treatment protocols by searching through my Substack archive.

Sources and References

The post Paxlovid Is a Fraud, When Will It Be Taken Off the Market? appeared first on LewRockwell.


Fight Censorship, Share This Post!

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.